339 filings
Page 11 of 17
S-3ASR
vlp817c 3aqnyj
1 Oct 21
Automatic shelf registration
4:03pm
8-K
b57hais szd3r
16 Sep 21
Departure of Directors or Certain Officers
4:02pm
4
dyguteb9me1zet0yf5ne
3 Sep 21
Kymera Therapeutics / Bruce N. Jacobs ownership change
5:57pm
4
ka8 nwvjdm0sknjm
27 Aug 21
Kymera Therapeutics / Richard Chesworth ownership change
4:55pm
4
anbeby6h0f629f4ch
19 Aug 21
Kymera Therapeutics / Richard Chesworth ownership change
4:30pm
4
tgm np6ag1mldhq16xez
19 Aug 21
Kymera Therapeutics / Nello Mainolfi ownership change
4:30pm
4
pkg09pduw4vbze8dw2
12 Aug 21
Kymera Therapeutics / Bruce Booth ownership change
10:43am
4
hi6hlo w0
12 Aug 21
Change in insider ownership
10:42am
8-K
hehn6 ohttqbtfn
6 Aug 21
Kymera Therapeutics Announces Second Quarter 2021 Financial Results and Provides a Business Update
7:10am
4
x57ramkfm5rve xw7
5 Aug 21
Kymera Therapeutics / Nello Mainolfi ownership change
4:14pm
4
bwc25q945l9b2 4jz5l
2 Aug 21
Kymera Therapeutics / Nello Mainolfi ownership change
5:53pm
4
q3e0xp lga
28 Jul 21
Kymera Therapeutics / Nello Mainolfi ownership change
4:57pm
4
3553j2ga
9 Jul 21
Kymera Therapeutics / Nello Mainolfi ownership change
4:30pm
4
jwxm0m
6 Jul 21
Kymera Therapeutics / VALUE FUND L P BIOTECHNOLOGY ownership change
6:40pm
424B4
ei7 ycrya2gk
2 Jul 21
Prospectus supplement with pricing info
4:09pm
EFFECT
a037 sbwdinrm9qyilyu
1 Jul 21
Notice of effectiveness
12:16am
S-1MEF
ii4k364j 4aqgv
30 Jun 21
Registration of additional securities for an S-1
8:40pm
8-K
yt6vqngf76vhrk
28 Jun 21
Kymera Therapeutics Announces Positive Interim Results from Single Ascending Dose Phase 1 Trial of KT-474 Demonstrating Degrader Proof-of-Mechanism
7:46am